PBE · Invesco Biotechnology & Genome ETF
Invesco Exchange-Traded Fund Trust
$99.22
+2.60%
At close · Oct 20
Net assets $281,946,188
Holdings33
1 month
+1.59%
Year to date
+22.10%
52-week range
$72.27–$99.75
30-session avg volume
13,779
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000003026
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings56.82%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC100.05%
STIV17.93%
Country allocation
US108.58%
GB4.94%
NL2.89%
KY1.56%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Invesco Private Prime Fund | $36,342,595 | 12.89% | |
| Regeneron Pharmaceuticals, Inc. | REGN | $15,430,293 | 5.47% |
| Amgen Inc. | AMGN | $14,721,971 | 5.22% |
| CareDx, Inc. | CDNA | $14,213,574 | 5.04% |
| Vertex Pharmaceuticals Inc. | VRTX | $14,055,366 | 4.99% |
| Invesco Private Government Fund | $14,001,686 | 4.97% | |
| Royalty Pharma PLC | RPRX | $13,930,997 | 4.94% |
| Biogen Inc. | BIIB | $13,497,596 | 4.79% |
| Gilead Sciences, Inc. | GILD | $12,503,545 | 4.43% |
| United Therapeutics Corp. | UTHR | $11,491,609 | 4.08% |
| Bio-Techne Corp. | TECH | $10,526,510 | 3.73% |
| Illumina, Inc. | ILMN | $9,892,178 | 3.51% |
| Protagonist Therapeutics, Inc. | PTGX | $9,572,315 | 3.40% |
| Vericel Corp. | VCEL | $9,205,696 | 3.27% |
| Alnylam Pharmaceuticals, Inc. | ALNY | $8,931,283 | 3.17% |
| Incyte Corp. | INCY | $8,621,695 | 3.06% |
| Repligen Corp. | RGEN | $8,574,395 | 3.04% |
| Acadia Pharmaceuticals Inc. | ACAD | $8,523,234 | 3.02% |
| Halozyme Therapeutics, Inc. | HALO | $8,413,220 | 2.98% |
| Qiagen N.V. | QGEN | $8,159,417 | 2.89% |
| BioMarin Pharmaceutical Inc. | BMRN | $7,950,309 | 2.82% |
| Neurocrine Biosciences, Inc. | NBIX | $7,502,497 | 2.66% |
| Exelixis, Inc. | EXEL | $7,431,836 | 2.64% |
| BioCryst Pharmaceuticals, Inc. | BCRX | $7,426,128 | 2.63% |
| Veracyte, Inc. | VCYT | $7,338,709 | 2.60% |
| Collegium Pharmaceutical, Inc. | COLL | $7,338,187 | 2.60% |
| Omeros Corp. | OMER | $7,118,646 | 2.52% |
| PTC Therapeutics, Inc. | PTCT | $7,041,823 | 2.50% |
| AnaptysBio, Inc. | ANAB | $6,469,740 | 2.29% |
| Sarepta Therapeutics, Inc. | SRPT | $6,243,875 | 2.21% |
| Ardelyx, Inc. | ARDX | $5,547,485 | 1.97% |
| Legend Biotech Corp. | LEGN | $4,399,986 | 1.56% |
| Invesco Government & Agency Portfolio | 825252885 | $215,965 | 0.08% |